Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
Rang in aandelen #38667
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Aandeelprijs
$0.04057595
Laatst gesynchroniseerd: 2024-08-05
Marktkapitalisatie
$863.62K
Verandering (1 dag)
0.31%
Verandering (1 jaar)
0.00%
Land
SE
Handel AegirBio AB (publ) (AEGIR)

Categorie

Dividendrendementgeschiedenis voor AegirBio AB (publ) (AEGIR)
Het dividendrendement (TTM) van AegirBio AB (publ) (aandelsymbool: AEGIR) per 2022-12-31 is: 0.00%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van AegirBio AB (publ) (AEGIR) van 2019 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten